Search

everythinglearnresearchcommunity

for

Search:↓

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

The new cream is safe and effective for mild to moderate atopic dermatitis.

Adding a second method to PROTACs could improve cancer treatment.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Scalp medⓇ effectively and safely improves hair growth in men with androgenetic alopecia.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Avacopan may cause unexpected side effects, so early monitoring is important.